I
t is generally accepted that epidemics of influenza A virus infection are of two distinct types: the first, which occur annually or biannually, are regional epidemics in partially immune populations, and the second, which occur at irregular and unpredictable intervals ranging from 11 to 30 years or more, confront essentially nonimmune populations and are global (pandemic) in distribution. Regional, or interpandemic, influenza is associated with progressive evolution of the virus by its acquisition of cumulative point mutations affecting antigenic sites of the hemagglutinin (HA) and neuraminidase (NA) antigens of the virus (antigenic drift), whereas pandemics follow the introduction of wholly new antigens, novel to human experience, probably through genetic reassortment of human and animal viruses (antigenic shift).
The worldwide influenza epidemic of influenza in 1947 after the close of World War II has never fit neatly into either epidemic category. So different were the strains of 1946-47 that initial classification of human influenza A viruses designated them as ''A prime'' (1) and somewhat later as ''H1'' in contrast to the ''H0'' designation of all earlier strains (2) . Currently, based principally on antigenic cross-reactivity and more recently and definitively on sequence homology, the H0 and H1 strains are grouped together in the H1 category, and thus this significant bit of history (and its categorical and epidemiological implications) has been forgotten (3) . On the basis of subsequent antigenic analysis and genomic sequence data, the 1947 virus is clearly of the H1N1 subtype, but the rapid post-World War II dissemination of the virus, the low levels of serum antibody to the virus in humans at that time (4) , and the almost total failure of a vaccine containing earlier H1N1 strains (5) have remained puzzling.
In short, the categorical analysis of the virus has not been in accord with its epidemiologic manifestations. In the present paper we demonstrate unidirectional antigenic changes in the prototype 1947 H1N1 strain, A͞Fort Monmouth͞1͞47, from the antecedent A͞Weiss͞43 virus (and another 1943 strain), that may explain both the failure of vaccine containing the Weiss strain and the extent of the 1947 epidemic.
Materials and Methods
Viruses and Their Genealogy. Strains of A͞Fort Monmouth͞1͞47 (H1N1) (FM-1) from three laboratories were compared initially and found to be similar in antigenicity and HA sequence. Thereafter, our studies focused on the strain present in the laboratory of one of us (E.D.K.) since 1951 and used previously in immunologic studies. This strain was known to be avirulent in mice and presumably was closest in genealogy to the strain initially isolated in eggs in 1947. A͞Weiss͞43 (H1N1) was a component [together with A͞PR͞8͞34 (H1N1) and B͞Lee͞40] of the 1947 vaccine. A second 1943 strain, A͞Marton͞43, was generously provided as lyophilized virus by H. F. Maassab (University of Michigan, Ann Arbor), and two others, A͞Huston͞43 and A͞DSP͞43, were from the files of the Centers for Disease Control. It is important to note that although both the Weiss and Marton strains had been isolated initially in ferrets (the principal experimental host used for influenza studies in 1943), in 1971 the Marton strain was reisolated from clinical material in eggs to create an egg passage line (E9), which has been used in this study. The principal strains and their passage histories before their use in the experiments described herein are listed in Table 1 .
Strains of the later period of H1N1 prevalence (1977-1986) include A͞USSR͞90͞77, A͞India͞6263͞80, A͞Chile͞1͞83, and A͞Taiwan͞1͞86. All of these strains had been isolated and passaged only in eggs. These latter strains had been examined extensively and compared previously with respect to their antigenic relationships (6) .
Antisera. Antisera used in hemagglutination-inhibition (HI) and NA-inhibition (NI) tests were prepared in rabbits as secondary response sera (6).
Serologic Testing. Serologic testing was done as described (6) . Antigenic relatedness was determined by the method of Archetti and Horsfall (7) by calculation of homologous and heterologous titer ratios. The formula used compensates for differing homologous titers of the antisera used in the analyses in order for antigenic relationships to be defined by a single value (see also ref. 6 ). Plaque-inhibition tests were carried out in Madin-Darby canine kidney (MDCK) cell monolayer cultures as described (8) .
Vaccination and Protection of Mice. BALB͞c female mice averaging 26 g in weight were injected i.p. with formalin-inactivated A͞Weiss͞43 virus as described in Results, bled for antibody studies 14 days after a second boosting infection (day 35), and then challenged by intranasal injection under light ether anesthesia with the indicated dose of virus. Lungs were removed 3 days after challenge and titrated for the presence of plaqueforming virus.
Nucleotide Sequencing. Viral RNA was purified directly from viral material with the Qiagen (Chatsworth, CA) RNeasy kit. The HA1 domain of the HA gene was amplified by reversetranscription followed by PCR. PCR-derived double-stranded DNA was used as a template for dye terminator sequencing by using a Model 373A or 3100 DNA sequencer (Amplicon Biosystems, Foster City, CA). Four primers complementary to the plus-sense RNA strand were used to sequence the HA1 domain. Five primers complementary to the plus-sense RNA strand were used to sequence the NA. The primers' sequencing is available on request.
The sequences generated in this study have been deposited in the GenBank database under the accession codes shown in Table  1 . The remaining sequences were obtained from the GenBank database. Table 2 . First, it is apparent that although the HA antigens of the 1943 strains were closely related (71%), the viruses were antigenically distinguishable from one another, particularly with respect to their NA antigens. Nonetheless, both 1943 strains stand apart from both 1947 strains. The 1947 strains resembled each other closely in that neither was inhibited significantly in HI tests by antisera to either Reciprocal of HI (H1) endpoint titers of polyclonal rabbit antisera titrated in duplicate. Results are expressed as initial serum dilutions prior to the addition of virus and red blood cells. 1943 virus, and antisera to the vaccine strain, Weiss, did not cause significant (i.e., Ͼ25%) inhibition of the 1947 viruses in NI tests. With respect to the HA antigens, relatedness was unidirectional in the sense that antibodies to Weiss antigens were virtually noninhibitory to either 1947 virus, although antibodies to the antigens of FM-1͞47 virus were inhibitory to, i.e., recognized epitopes in, the antecedent Weiss and Marton strains. The markedly diminished inhibition of post-1943 viruses by antisera to both Weiss and Marton viruses is summarized in Table 3 .
Results

Antigenic
Similarly, tests of in vitro neutralization of virus infection in Madin-Darby canine kidney cell cultures (data not shown) demonstrated not only virus dissimilarity but a lack of measurable effect of Weiss antiserum on suppression of FM-1 virus replication. The fact that Weiss antiserum had no significant effect on FM-1 virus in any test suggests that both HA and NA antigens had mutated significantly, an inference later supported by the studies of HA and NA sequences described below. A similar lack of effect on FM-1 virus replication was found with antiserum to the still earlier A͞PR͞8͞34 H1N1 virus strain also used in the 1947 vaccine (data not shown).
Differences among the NA antigens of 1943 and 1947 strains are less extensive than with the HA antigens, and Weiss and Marton are discordant with respect to their inhibition of the Rhodes͞47 NA. (Tables 5 and 6 ). Antigenic cross-reactivity was seen among the four strains studied, and although progressive diminution of inhibition was observed, in no case was antibody to earlier strains nonreactive with subsequently emerging viruses, even after 9 years. The results shown in plaque-reduction tests are particularly significant, because these tests in cell cultures measure effects on actual in vitro infection and reflect the presence of both neutralizing or plaque size-reducing antibodies (8) .
Studies of HA and NA Nucleotide Sequences. Although differences in antigenic phenotype were the critical point of departure for this study, such differences (or similarities) are not definitive criteria for the establishment of genealogical relationships among viruses. Therefore, complete HA1 and NA nucleotide sequences were obtained and analyzed. Amino acid sequences were deduced and then analyzed with reference to the number of differences overall between viruses and with respect to their known antigenic sites. In this later period, spanning 9 years, no abrupt antigenic change of the same magnitude is seen comparable to that which occurred between 1943 and 1947 with the Weiss͞43 and FM-1͞47 viruses. *Reciprocal of serum dilution at the endpoint. (Table 7, [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] ). Robertson noted five amino acid substitutions between residues 189 and 197 comprising part of the Sb site at the antigenically significant tip of the HA molecule (10) . It is worth noting that in a crowded boys' school population, vaccine containing the preceding Chile strain had little effect on two successive epidemics from which Taiwan-like virus was recovered (11) . No changes from the USSR͞77 strain occurred in any of the strains at the Ca1 and Cb sites (data not shown in Table 7 ).
Comparative Number of HA Amino Acid Changes During the Early and
Late Periods of H1N1 Prevalence. Table 8 contrasts the changes in a 4-year interval in the case of the early strains with 3-9-year intervals in evolution of the later viruses. The general point to be made is the Ϸ2-fold greater number of total changes in HA1 comparing the Weiss-to-FM-1 4-year period with the USSR-toChile interval of 6 years. Furthermore, the earlier changes involved five antigenic sites rather than only one in the later period. Even after 9 years, in the case of Taiwan virus, changes involved only two sites. Previous studies of sequential variants of epidemiological importance have revealed that, in general, each significant drift variant has at least four amino acid substitutions located in two or more defined antigenic sites (12) . Tables 9 and 10 ). In contrast to the situation with the HAs of the 1943 and 1947 viruses in which sharp differences are evident in both antigenic and nucleotide sequence analyses, analyses of the NAs are less easy to interpret and present some dichotomies. To begin with, all four NAs are cross-reactive antigenically to some degree. By sequence analysis, Marton͞43 and Rhodes͞47 are almost identical, although they are less related on antigenic analysis. Their similarity cannot be ascribed to host-passage histories, which are very different (see Table 1 ).
Changes in NA Antigenic Sites (See
On the other hand, the NAs of the two 1947 strains have in common only 39 of 49 amino acids (78%) in antigenic sites yet are Ϸ100% related antigenically. A more extreme dichotomy has been observed with two HA variants of A͞Shanghai͞11͞87 (H3N2), which, although only 40% antigenically related by analysis with polyclonal rabbit antibody, differed by only a single amino acid at HA1 site 186 (13) . Such occasional nonconcordances are to be expected, depending on the location of the specific sites involved in virus-antibody reactions, because they may or may not affect functionally important sites on viral surface proteins. Furthermore, the determination of antigenic relationships can be influenced by the species of antibody and the method of immunization used (13, 14) .
There are precedents for the cocirculation of intrasubtypic NA variants (15, 16) and also for the slower evolutionary rate of NA proteins (6) . In the present case, perhaps genetically distinguishable but antigenically similar NAs have arrived at the same place by convergent evolution under the suppressive effects of population antibody evident even before 1943.
Antigenic site changes in the NAs of the 1977-1986 period were minimal in the first 6 years and until the introduction of the Taiwan͞86 strain at the end of the 9-year period.
Discussion
A cardinal concern in this revisitation of the past of viruses over 50 years old is how representative these viruses may be of those circulating at that time, recognizing that with repeated laboratory passage such viruses are subject to ''laboratory drift'' and 
Shown are only the antigenic sites in which amino acid changes have occurred, and then only the amino acid positions that have changed are shown; there are actually 46 amino acids in 8 antigenic sites. *This antigenic site is not defined as an antigenic site for N2 but it is included here because there are significant changes at this site in the N1 model. changes associated with isolation or passage in different host systems (17, 18) . Virus changes associated with host adaptation have been associated often with single site mutations of the HA, which pleiotropically can have minor effects on antigenicity (13, 19) . We have taken pains to employ two of the few available representatives of both the 1943 and 1947 periods in our present analysis and have shown that they differ within each year in amino sequences involving their antigenic sites despite the fact that one virus in each year (Weiss͞43 and Rhodes͞47) had been recovered initially in ferrets. In comparisons of 1943 with 1947 strains, regardless of origin, marked and similar differences were discerned. This result was not unexpected in view of the failure of the 1943 vaccine in healthy young soldiers in 1947 and our present demonstration of 3-5% antigenic relatedness of the HAs of the viruses of the two periods. It should be stressed that differences of this degree are more characteristic of intersubtype HA differences caused by the importation of novel antigens from animal sources (17) than variations within a subtype. The vaccine failure of 1947 clearly was not the result of administration of a nonimmunogenic vaccine: (i) homologous response to the Weiss component was good (4), (ii) the vaccine was protective in the 1943-44 and 1944-45 epidemics (1, 20) , and (iii) in our animal model a freshly made Weiss-strain vaccine failed to reduce replication of FM-1 virus in mice but was protective against Weiss-virus challenge. Similarly, tests of standard (National Institutes of Health) vaccine in 1947 failed to raise neutralizing antibodies in mice against either the FM-1 or LF1 1947 strains, but even when highly diluted it did induce neutralizing antibodies to its component Weiss and PR8 viruses (4) . Why did a virus as different as FM-1͞47 not cause pandemic infection? In the sense of global distribution of the virus, it did, but other signs of true pandemic disease were lacking, including notably a significant effect on mortality, although disease in young military patients was as severe as in earlier epidemics (21) . It is possible (even probable) that in a population experienced with H1N1 viruses, no matter how apparently different with respect to HA and NA antigens, a degree of immunity to FM-1-like strains existed sufficient to moderate the epidemic but insufficient to prime for an adequate heterovariant vaccine response. Also, the 34-65% antigenic relationship of the NA antigens of our two 1947 strains to the Marton 1943 strain hints at the possibility of some cross protection through the NA antigens such as that seen in the pandemic of 1968 (22) .
The question arises, ''whence came the viruses of 1947?'' Probably not as mainstream extensions of the Weiss-like viruses of 1943. More likely, as Nakajima et al. (23) have suggested in the case of the Taiwan-like viruses of 1986, they emerged as a side branch from other H1N1 viruses of the earlier period that had not produced significant epidemics at that time. Indeed, an exception to the good protection afforded to most troops vaccinated with Weiss-containing vaccine in 1943-44 was encountered at one installation in California in which the incidence of influenza was less moderated than in other outbreaks studied at the same time (20) , and the virus isolated from the outbreak differed slightly from the Weiss vaccine antigen. Unfortunately, this ''Olsen strain'' is not available for study.
The present study is important in demonstrating an extreme of intrasubtypic antigenic variation that, under other circumstances with a virus of greater intrinsic virulence, might present a pandemic threat even without the recruitment of novel antigens from animal sources. 
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